Sign in
4

Changes in Ownership

RIGEL PHARMACEUTICALS INC Filed Acc 0001179110-18-007150

Options or other derivatives

  • Director acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LAPOINTE ANTHONY GREGG · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-05-17 Grant or award : show line 1 in the form Stock Option (Right to Buy) +30,000 $3.98 2028-05-17 30,000 30,000 D
Loading xslF345X03/edgar.xml…